The most important medtech leadership changes of 2023

Former Johnson & Johnson EVP and MedTech Worldwide Chair Ashley McEvoy [Photo courtesy of Johnson & Johnson]

From hirings and firings to promotions, resignations and surprising shake-ups, these were the most important medtech leadership changes of the year.

By Associate Editor Sean Whooley and Managing Editor Jim Hammerand

The leadership change at Johnson & Johnson MedTech was a surprising shift that ended up as the year’s biggest medtech leadership change of 2023.

In October, J&J EVP and J&J MedTech Worldwide Chair Ashley McEvoy announced her resignation from the world’s second-largest device manufacturer. She’s staying on into the first quarter of 2024 while her successor, Tim Schmid, gets settled into his new role.

Schmid, a 30-year J&J vet who was most recently company group chair of J&J MedTech Asia Pacific, said he’s “committed to building ev…

Read more
  • 0

Former Insulet exec named DermTech president and CEO

Bret Christensen. [Image from Insulet]DermTech (Nasdaq:DMTK) announced today that it appointed Bret Christensen as president, CEO and a member of the board.

Christensen previously served as chief commercial officer at automated insulin delivery technology developer Insulet. He departed last week as part of a handful of executive changes at the company.

The new CEO success Dr. John Dobak, who stepped down from his positions as president, CEO and board director.

“I am excited to be leading the DermTech team,” Christensen said. “DermTech has an opportunity to transform dermatology with its revolutionary technology, strong demand and building momentum with commercial payers. Importantly, I am confident that we can improve lives and integrate our test into the melanoma care pathway. I look forward to working closely with the board and the DermTech team to drive our average selling price, grow revenue and scale our business.”

About DermTech and it…
Read more
  • 0